<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT921-10107</title>
	</head>
	<body>
		<main>
			<p>920207 FT  07 FEB 92 / UK Company News: Wellcome sells subsidiary to Intl Murex for Pounds 15m Wellcome, the UK pharmaceutical group, has agreed to sell its diagnostics business to International Murex Technologies for Pounds 15m. Wellcome Diagnostics develops, manufactures and markets internationally, kits for the detection and diagnosis of disease and disease-causing organisms. In the year to August 31, the business recorded sales of Pounds 40m. Under the agreement, the Wellcome diagnostic business worldwide has been transferred to International Murex, including approximately Pounds 22m of net assets. Mr John Robb, Wellcome's chief executive, said the divestiture of the diagnostics business confirmed Wellcome's intention to concentrate on its main pharmaceutical activity, while ensuring that the diagnostics business would continue.</p>
		</main>
</body></html>
            